LaSalle Street Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $686K | Hold |
9,412
| – | – | 0.8% | 47 |
|
|
2019
Q2 | $774K | Hold |
9,412
| – | – | 0.91% | 43 |
|
|
2019
Q1 | $664K | Sell |
9,412
-768
| -8% | -$54.2K | 0.78% | 45 |
|
|
2018
Q4 | $458K | Buy |
10,180
+677
| +7% | +$30.5K | 0.66% | 54 |
|
|
2018
Q3 | $537K | Buy |
9,503
+2,989
| +46% | +$169K | 0.63% | 56 |
|
|
2018
Q2 | $435K | Sell |
6,514
-2,873
| -31% | -$192K | 0.43% | 71 |
|
|
2018
Q1 | $547K | Sell |
9,387
-299
| -3% | -$17.4K | 0.43% | 73 |
|
|
2017
Q4 | $624K | Buy |
9,686
+1,367
| +16% | +$88.1K | 0.43% | 70 |
|
|
2017
Q3 | $437K | Buy |
8,319
+3,246
| +64% | +$171K | 0.32% | 76 |
|
|
2017
Q2 | $237K | Hold |
5,073
| – | – | 0.19% | 80 |
|
|
2017
Q1 | $251K | Buy |
+5,073
| New | +$251K | 0.21% | 81 |
|
|
2016
Q3 | – | Sell |
-4,383
| Closed | -$245K | – | 90 |
|
|
2016
Q2 | $245K | Buy |
+4,383
| New | +$245K | 0.23% | 71 |
|
|
2016
Q1 | – | Sell |
-4,574
| Closed | -$206K | – | 82 |
|
|
2015
Q4 | $206K | Buy |
+4,574
| New | +$206K | 0.2% | 80 |
|